Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose R Arribas

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|July 30, 2004
The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimensJose R Arribas
Current Opinion in HIV and AIDS|January 6, 2010
Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine)Jose R Arribas
Current Opinion in HIV and AIDS|May 14, 2013
Advances in antiretroviral therapyJose R Arribas, Joseph Eron
Current HIV/AIDS Reports|February 25, 2012
Protease inhibitor monotherapy: what is its role?Miriam Estébanez, Jose R Arribas
Current Opinion in Infectious Diseases|December 15, 2010
Protease inhibitor monotherapyIgnacio Pérez-Valero, Jose R Arribas
BMJ (Clinical Research Ed.)|December 11, 2025
How recent is recent? Retrospective analysis of suspiciously timeless citationsAlejandro Díez-Vidal, Jose R Arribas
Expert Opinion on Drug Safety|December 5, 2017
A safety evaluation of raltegravir for the treatment of HIVRosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in RealityLaura Waters, Rosa de Miguel-Buckley, Sébastien Poulin, et al.
The Journal of Infectious Diseases|June 26, 2018
Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus DiseaseJoanna Luczkowiak, Fatima Lasala, Marta Mora-Rillo, et al.
Current HIV/AIDS Reports|January 22, 2018
New Strategies of ARV: the Road to SimplificationRosa de Miguel Buckley, Rocio Montejano, Natalia Stella-Ascariz, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|July 30, 2004
The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimensJose R Arribas
Current Opinion in HIV and AIDS|January 6, 2010
Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine)Jose R Arribas
Current Opinion in HIV and AIDS|May 14, 2013
Advances in antiretroviral therapyJose R Arribas, Joseph Eron
Current HIV/AIDS Reports|February 25, 2012
Protease inhibitor monotherapy: what is its role?Miriam Estébanez, Jose R Arribas
Current Opinion in Infectious Diseases|December 15, 2010
Protease inhibitor monotherapyIgnacio Pérez-Valero, Jose R Arribas
BMJ (Clinical Research Ed.)|December 11, 2025
How recent is recent? Retrospective analysis of suspiciously timeless citationsAlejandro Díez-Vidal, Jose R Arribas
Expert Opinion on Drug Safety|December 5, 2017
A safety evaluation of raltegravir for the treatment of HIVRosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in RealityLaura Waters, Rosa de Miguel-Buckley, Sébastien Poulin, et al.
The Journal of Infectious Diseases|June 26, 2018
Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus DiseaseJoanna Luczkowiak, Fatima Lasala, Marta Mora-Rillo, et al.
Current HIV/AIDS Reports|January 22, 2018
New Strategies of ARV: the Road to SimplificationRosa de Miguel Buckley, Rocio Montejano, Natalia Stella-Ascariz, et al.
Pageof 7